SSTR2
Somatostatin receptor type 2
Also known as: SSR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30874
- Gene
- SSTR2
- Ensembl
- ENSG00000180616
- Chromosome
- 17
- Canonical length
- 369 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biologic effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR2 is a member of the superfamily of receptors having seven transmembrane segments and is expressed in highest levels in cerebrum and kidney. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>P30874|SSTR2
1 MDMADEPLNG SHTWLSIPFD LNGSVVSTNT SNQTEPYYDL TSNAVLTFIY FVVCIIGLCG
61 NTLVIYVILR YAKMKTITNI YILNLAIADE LFMLGLPFLA MQVALVHWPF GKAICRVVMT
121 VDGINQFTSI FCLTVMSIDR YLAVVHPIKS AKWRRPRTAK MITMAVWGVS LLVILPIMIY
181 AGLRSNQWGR SSCTINWPGE SGAWYTGFII YTFILGFLVP LTIICLCYLF IIIKVKSSGI
241 RVGSSKRKKS EKKVTRMVSI VVAVFIFCWL PFYIFNVSSV SMAISPTPAL KGMFDFVVVL
301 TYANSCANPI LYAFLSDNFK KSFQNVLCLV KVSGTDDGER SDSKQDKSRL NETTETQRTL
361 LNGDLQTSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SSTR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 18 nTPM
- cerebral cortex: 13 nTPM
- basal ganglia: 6.6 nTPM
- spleen: 5.7 nTPM
- kidney: 5.4 nTPM
- hippocampal formation: 5.3 nTPM
Single-cell type
- proximal tubule cells: 12 nCPM
- papillary tip epithelial cells: 5.3 nCPM
- renal collecting duct principal cells: 4.6 nCPM
- neuroendocrine cells: 3.5 nCPM
- pericytes: 3.2 nCPM
- loop of henle epithelial cells: 2.7 nCPM
Immune cell
- basophil: 1.2 nTPM
- neutrophil: 1.1 nTPM
- eosinophil: 0.3 nTPM
- naive B-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- gdT-cell: 0.2 nTPM
Brain region
- hippocampal formation: 25 nTPM
- pons: 25 nTPM
- basal ganglia: 24 nTPM
- cerebral cortex: 24 nTPM
- cerebellum: 21 nTPM
- white matter: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.44
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- cellular response to estradiol stimulus
- cellular response to glucocorticoid stimulus
- G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- negative regulation of cell population proliferation
- neuropeptide signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SSTR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SSTR2 as an antibody target. Whether an autoantibody or antibody against SSTR2 could matter depends on whether native SSTR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SSTR2 is annotated at the cell surface, where native SSTR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SSTR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...